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Abstract
Objective: In jawbones, ameloblastomas and odontogenic keratocysts share many clinical features in common 
such as aggressiveness, high recurrence rates and radical management options. Understanding the pathogenesis 
and biological aspects of these tumors would improve the success of diagnose and treatment procedures.  The 
aim of this study was to exhibit the reasons of high recurrence rates and growth potentials of ameloblastomas and 
keratocystic odontogenic tumours by investigating the expression of IL-1α and IL-6 and IL-1α -889 gene polymor-
phism. IL-1α and IL-6 are shown as very effective tissue degrading factors in bone remodelling.
Study Design: This study included 25 cases of ameloblastomas, 41 cases of keratocystic odontogenic tumors (par-
akeratinized odontogenic keratocysts) and 8 cases of orthokeratinized odontogenic keratocysts. All histological 
slides were stained immunohistochemically to show the expression of IL-1α and IL-6. Restriction fragment length 
analysis was used to investigate the cytokine gene polymorphism.
Results and Conclusions: The higher expression rates of IL-1α and IL-6 were associated with tumor size in amel-
oblastomas and with cyst wall thickness in keratocystic odontogenic tumors. This finding suggested us that the 
cytokines IL-1α and IL-6 play a role on aggressive behaviour of ameloblastomas and keratocystic odontogenic 
tumors by making easy bone resorption. In addition, IL-1α (-889) T polymorphism was found consistent with 
increased IL-1α expression but not seem as a risk factor on the development of these tumors. 
Key words: Ameloblastoma, odontogenic keratocyst, keratocystic odontogenic tumor, interleukin, single nucle-
otide polymorphism.
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Introduction
Understanding the pathogenesis and biological behavior 
of odontogenic cysts and tumors would improve our suc-
cess at diagnosis and treatment. Ameloblastomas and 
odontogenic keratocysts share many clinical features in 
common such as local aggressiveness, high recurrence 
rates and radical management options (1). 
Ameloblastomas are the most common odontogenic 
tumors characterized by its histological resemblance to 
the enamel organ (2-5). Partial maxillectomy or man-
dibulectomy is the most common treatment choice with 
safety margin of healthy bone to avoid recurrence (6). 
World Health Organization (WHO) working group rec-
ommends the term of keratocystic odontogenic tumor 
which stresses the neoplastic nature of the entity instead 
of odontogenic keratocyst for parakeratinized variants 
(5,7,8). A more “innocent” entity ortokeratinized odon-
togenic keratocyst (OKK) is not included in this novel 
classification, is still classified in developmental odon-
togenic cysts (5,9). 
Keratocystic odontogenic tumor (KOT) has an aggres-
sive growth potential and a tendency to recur. KOTs 
have a thin fibrous capsule with a lining of parakerati-
nized squamous epithelium which has a high mitotic 
activity (9,10). 
Inflammatory cytokins such as interleukin 1 (IL-1), 
interleukin 6 (IL-6) and tumor necrosis factor (TNF) 
play important roles in bone resorption by inducing the 
production of matrix metalloproteinase like degrada-
tive enzymes and prostaglandins and/or differentiation 
and activation of osteoclast-like cells (11-13). The gene 
encoding IL-1α is found on chromosome 2q13-21 and 
there is a single nucleotide polymorphism at position 
-889. IL-1α -889 C/T polymorphism has been reported 
to be associated with an increased cytokine production 
(14-16). Cytokine levels, especially osteolytic cytokines 
found in intracystic fluids of cysts or expressed by the 
cells may play an important role on growth of amelob-
lastomas and keratocystic odontogenic tumors in jaws 
(1,17,18). 
In this research, we studied the expression of IL-1α 
and IL-6 by immunohistochemistry in ameloblasto-
mas, KOTs and keratocystic odontogenic cysts with the 
theory of high expression of these cytokines may be a 
cause of reaching large sizes by bone destruction. Also 
we aimed to examine the influence of IL-1α -889 poly-
morphism on tumor size or recurrence because of its 
effect on IL-1α protein expression. 
Material and Method
Twenty-five ameloblastomas, 41 KOTs and 8 OKKs 
were selected from the archive of Gazi University Den-
tal Faculty Oral Pathology Department. Fifteen dental 
follicles and 15 dentigerous cysts used as control tis-
sues. Tumor and cyst sizes that noted during macro-
scopical examination were reviewed and graded as fol-
lows: Maximum diameter between 0.5-1.9 cm: grade 1, 
2.0-2.9 cm: grade 2, 3.0-3.9 cm: grade 3 and 4 cm and 
more: grade 4.
Haematoxyline-eosin stained sections were used for 
grading the inflammation intensity as described before 
(19). Leica QWin Plus v3.3.1 (Leica Microsystems GmbH. 
Wetzlar, Germany) image analyze program was used to 
evaluate the cyst wall thicknesses of KOT and OKK. 
Immunohistochemistry 
The study of the expression of IL-1α and IL-6 were con-
ducted by a technique of avidin-biotin-peroxide com-
plex (ABC). Sections were incubated with rabbit poly-
clonal anti-IL-1α (IL-1α rabbit polyclonal antibody, cat 
# ab7632, Abcam, Cambridge, UK) and goat polyclonal 
anti-IL-6 (IL-6 goat polyclonal antibody, Lot: sc-1265, 
Santa Cruz Biotechnology, Inc. CA, U.S.A) antibod-
ies overnight at 4oC. The dilutions of antibodies were 
1:25 and 1:50 in PBS, respectively. On the following 
day, they were incubated with biotinylated secondary 
antibody and ABC by using Zymed Histostain Plus kit 
(Zymed laboratories Inc., Carlsbad, CA, USA) and San-
ta Cruz goat ABC staining system (ABC kit, Lot: sc-
2023, Santa Cruz Biotechnology, Inc. CA, U.S.A). 3-3’ 
diaminobenzidine tetrachloride (DAB) was added to 
sections and incubated for 3-5 min. Sections were coun-
terstained with haematoxyline. Positive control tissues 
were tonsil for both antibodies. The red-brown cyto-
plasmic staining was considered as positive. The stain-
ing intensity for antibodies was regarded intense (+++), 
moderate (++), mild (+) and negative (-) as Kubota et al. 
suggested (1).
Gene polymorphism
Polymorphism at position -889 of the IL-1α was analysed 
by PCR-restriction fragment length polymorphism. 
Sections from paraffin blocks were deparaffinized with 
xylene and genomic DNA was isolated with a commer-
cial DNA extraction kit (High Pure Viral Nucleic Acid 
Kit, Roche Diagnostics, Germany) according to the man-
ufacturer’s instruction. For IL-1A  promoter genotyping 
DNA was amplified by polymerase chain reaction using 
the  primers 5` AAG CTT GTT CTA CCA CCT GAA 
CTA GGC 3`and 3` TTA CAT ATG AGC CTT CCA 
TG 3` as forward and reverse. For each reaction 10 ng of 
genomic DNA was used as template and amplified us-
ing 2mM of dNTPs, 100 pmol/µl of each primers, 1.0 U 
of taq DNA polymerase with buffer containing MgCl2. 
The reaction incubated for 7 min at 950C, followed by 
35 cycles of 1 min at 940C, 1 min at 550C and 1 min at 
720C and a final extension of 720C for 5 min. The prod-
ucts were digested with 1 U per 25 µl reaction of NcoI 
at 370C overnight. For analysis of IL-1α polymorphism, 
reaction products were separated by electrophoresis 
on 4% agarose gels containing ethidium bromide and 
viewed under ultraviolet transillumination.
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Statistical analysis
The statistical analyses were carried out using SPSS 
(Version 12.0, SPSS Inc., and Chicago, USA) software 
program. Bivariate analyses were used with the level of 
significance set at P value ≤ 0.05. Univariate analysis 
was performed by using logistic regression analysis to 
identify possible predictors of ameloblastoma or kerato-
cystic odontogenic tumor. 
Results
By immunohistochemistry, expressions of IL-1α and 
IL-6 were detected selectively in stellate reticulum-like 
cells in ameloblastomas but not in basal cells of tumor 
islands (Fig. 1) and throughout the lining epithelial cells 
in KOT and OKK (Fig. 2). Staining was also seen in the 
inflammatory cells and endothelial cells of some capil-
laries. Control tissues showed no or only slight staining 
for both cytokines neither in lining epithelium nor in 
connective tissue.
In the stellate reticulum-like tumor cells of ameloblasto-
mas, staining intensity of IL-1α was mostly moderate (++) 
and intense (+++) (10 of 25 specimens). In 5 cases staining 
density was mild; there was no case not showing IL-1α ex-
pression. IL-6, on the other hand, was negative in 11 cases 
and mostly mild to moderate in the remaining. 
In KOTs more cases showed mild staining for IL-1α and 
moderate staining for IL-6. OKK showed nearly equal 
distribution in the staining density for both cytokines 
(Table 1).
Although the obtained values were not statistically 
significant, a correlation was determined between the 
expression of both cytokines and tumor size in amel-
oblastomas.
There was a correlation between the expression of IL-6 
in the lining epithelium and the thicknesses of cyst wall 
KOTs (R=0.322, P=0.020). The same correlation was 
seen between the IL-6 expression in inflammatory cells 
and the thickness of cyst wall (R=0.544, p<0.001). 
Expression grades of both cytokines in lining epithe-
lium of KOTs were significantly higher than in OKK 
(p=0.026, p=0.001).
The distribution of the IL-1α -889 genotype and allele 
frequencies in all cases and controls are summarized in 
(Table 2). 
There was no significant difference between the patients 
with ameloblastoma, KOT and OKK or controls with re-
spect to the genotype and allele frequencies (p>0.05). 
Fig. 1. IL-1α (a) and IL-6 (b) expressions in stellate reticulum-
like cells in ameloblastomas (a, b: x100, DAB). 
Fig. 2. IL-1α (a) and IL-6 (b) expressions in lining epithelium 
in keratocystic odontogenic tumor and in the inflammatory and 
endothelial cells (a, b: x100, DAB). 
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When the genetic and immunohistochemical findings 
compared in patients with IL-1A (CC) and (CT+TT) 
genotypes, increasing T allele frequency resulted in 
higher IL-1α expression (p<0.001). Besides cases with 
IL-1A (CT+TT) genotypes have larger sizes than the 
cases with IL-1A (CC) genotype. 
T allele carriage frequency was higher in ameloblasto-
mas than KOT and OKK. But this finding was not sta-
tistically significant. 
The allelenic frequency of IL-1α -889 did not deviate 
significantly from Hardy- Weinberg equilibrium that 
predicted. 
Discussion
IL-1α and IL-6 are major cytokines that responsible for 
osteolysis (20). The osteolytic properties of IL-1α and 
IL-6 are consistent with their possible role upon intra-
osseous growth and expansion of ameloblastomas and 
KOT (1,18). 
We demonstrated that IL-1α and IL-6 is expressed in 
stellate reticulum-like cells in ameloblastomas as Pri-
patnanont et al. (17) showed before.  Also gave evidence 
of the source of IL-1α in ameloblastomas by cytokine 
mRNA hybridization (17). As an advantage of immuno-
histochemistry, we showed the source of IL-1α and IL-6 
in ameloblastomas is stellate reticulum-like cells. 
IL-1α protein has been shown in epithelial stellate re-
ticulum cells in teeth germs in rats indicating that these 
cells are the main sources for IL-1α secretion (21).  As 
it is known, the tooth eruption is a complicated proc-
ess that occurs between dental follicle and alveolar bone 
and requires osteoclastic activity (22,23). IL-1α which 
is synthesized by unerupted teeth germs is the principal 
cytokine that responsible for differentiation and activa-
tion of monocytes to osteoclasts (22). Therefore, IL-1α 
may play important role in teeth eruption.
We found a positive relationship between increased 
IL-1α and IL-6 expressions and tumor size in group of 
 Immunostainings IL-1Į (n) IL-6 (n) 
Ameloblastomas (n=25) 
-
+
++ 
+++ 
0
5
10
10
11
7
4
3
Keratocystic odontogenic tumors 
(n=41) 
-
+
++ 
+++ 
6
12
12
11
3
15
18
5
Odontogenic keratocycts (n=8) 
-
+
++ 
+++ 
2
3
1
2
3
2
3
0
Table 1. Immunostaining of IL-1α and IL-6 in ameloblastomas, keratocystic odontogenic tumors 
and odontogenic keratocysts. 
Ameloblastoma
Keratocystic 
odontogenic
tumor
Odontogenic
keratocyst CONTROLS 
Genotype % n (25) % n (41) % n (8) % n(30)
CC (1/1) 48 12 65.8 27 62.5 5 53.3 16
CT(1/2) 36 9 19.5 8 37.5 3 33.3 10
TT(2/2) 16 4 14.6 6 0 0 13.3 4
Allele 
C (1) 66 33 75.6 62 81.25 13 64 42
T (2) 34 17 24.4 20 18.75 3 36 18
Table 2. IL-1α -889 allele and genotype distribution in patients and control groups. 
Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e467-72.                                                                                                      Interleukin expression and gene polymorphism in odontogenic tumors 
e471
 References with links to Crossref - DOI    
ameloblastomas. So, it is not hard to say that IL-1α and 
IL-6 should play important role in tumor expansion in 
jawbones by mediating bone lyses, exactly like materi-
alize in teeth eruption.  Kubota et al. (1) showed strong 
relationship between cytokine expression and matrix 
metalloproteinase (MMP) -2 and MMP-9 production 
in ameloblastomas that refers the role of cytokin and 
enzimatic activity in tumor spreading within the bone 
trabeculas. These cytokines may cause bone resorp-
tion by either stimulate differentiation and activation 
of osteoclasts or regulate production and secretion of 
degrading enzymes like MMPs (11,24). Since this in-
formation is very difficult to obtain, we do not know 
the growing time of tumors. Proliferation potentials and 
possible growing times of tumors in further investiga-
tions could be very valuable for sure. 
Our study showed that expressions of IL-1α and IL-6 
were in lining epithelial cells of KOTs and OKK as Pri-
patnanont et al. (17) and Ninomiya et al. (18) showed 
before. We also observed that staining intensities of IL-
1α and IL-6 in the lining epithelium of KOT and OKK 
were stronger than endothelial cells and fibroblasts in 
the connective tissue of these lesions. We suggested that 
growth potential of the cysts –or cystic tumors- in the 
jawbones is principally directed by the properties of the 
lining epithelial cells. Epithelial proliferation is efficient 
in KOT growth rather than osmotic pressure. Multicen-
tric pattern, semi-solid areas and keep growing if not 
treated support this idea (5,9). Like most of other cy-
tokines IL-1α and IL-6 play role in epithelial cells as 
growth factor (11,12). It can be proved by showing IL-
1α and IL-6 expressions with proliferation markers like 
PCNA or Ki67 at the same time. 
There was statistically significant relationship between 
IL-6 expression and connective tissue thickness in KOT 
and OKK. Increased IL-6 expression in lining epithelial 
cells and inflammatory cells is thought to play a role in 
fibroblast proliferation as a growth factor and/or produc-
tion of extracellular matrix components from fibroblasts. 
Expression of IL-1α and IL-6 in KOT was significantly 
higher than in OKK. Although there were no statistical-
ly significant differences between two groups for age, 
gender, cyst wall thickness or lesion size, the different 
levels in IL-1α and IL-6 expressions should be consid-
ered important. Positive relationship between lesion size 
and cytokine expression was striking only in KOTs in 
which recurrences and multiplicity was observed. Based 
on this finding it can be concluded that IL-1α and IL-6 
proteins play important role on the aggressive behavior 
of KOT in jawbones. Expressions of both cytokines in 
control tissues were significantly lower than in amelob-
lastomas, KOTs, and OKKs. Dentigerous cysts and den-
tal follicles rarely reach significant sizes in jaw bones 
unlike ameloblastomas and KOTs. Weak expression of 
IL-1α and IL-6 could be an additional reason.
IL-1 gene, located on chromosome 2q13-21, encodes 
pro-inflammatory cytokine (14). Several IL-1 gene 
polymorphisms have been described and reported as-
sociations with inflammatory disease (15,25,26). In the 
present study we studied the biallenic polymorphism at 
position IL-1α -889 representing a C/T single-nucleotide 
polymorphism. 
Our study was the first to analyze the polymorphism 
in the IL-1α (-889) gene in ameloblastomas, KOT and 
OKK. There was no statistically significant difference 
between the lesional and control (dentigerous cysts and 
dental follicles) tissues on the frequencies of alleles and 
genotypes (Table 2). Number of the cases, although not 
high, was enough to say that IL-1α -889 polymorphism 
does not indicate a risk of forming ameloblastoma, KOT 
or OKK. The very high values we observed also sup-
ported the strong evidence of lack of correlation, despite 
our limited samples. 
According to immunnohistochemical outcomes, in-
creasing T allele frequency resulted in higher IL-1α 
expression. Although statistical difference was not 
reached, our data pointed out a relationship of T allele 
frequency and tumor size. Recent studies showed that 
IL-1α -889 polymorphism increases the secretion of IL-
1α (15,27). 
The prevalence of T allele was higher in ameloblasto-
mas, comparing with both KOT and OKK. There is no 
doubt ameloblastoma is a true neoplasia. Indeed, recent 
studies highlighted the role of IL-1α in the development 
of tumors in several cancers (28). Polymorphism in this 
specific cytokines affects the activity and the amount of 
protein, gene transcriptions and the stability of mRNA 
(16). Therefore, IL-1α gene polymorphism is thought to 
play a role in tumor development. 
As a result, IL-1α -889 polymorphism is not a candidate 
gene alone in disease predisposition but plays an impor-
tant role in progression, particularly on tumor size. On 
the other hand, examining the other genetic loci regulat-
ing IL-1α synthesis in IL-1 gene family may be impor-
tant. Accumulated effects of many polymorphisms and/ 
or their interactions with each other are more possible to 
be determinant on phenotypic features of diseases. 
Showing the relationship between any single nucleotide 
polymorphism and tumor development and prognosis 
requires a long-term approach because of many other 
parameters and mechanisms also involve in this com-
plicated process.  
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